ITI-1020(Intra-Cellular Therapies)

N/A

Report date: 2024/08/12 17:58:21
NME

Base Information

Drug NameITI-1020(Intra-Cellular Therapies)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 1 inhibitors
TargetsPhosphodiesterase 1
Therapy Area/IndicationsTriple Negative Breast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntra-Cellular Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntra-Cellular Therapies Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A